drug

avalglucosidase alfa

1 story · latest Jul 7, 2026

Status: Investigational
Brand: Nexviadyme
Code: GZ402666
Trials: 1 registered trial in coverage

Relationships

Developed by Sanofi

Timeline

Sanofi's Nexviazyme meets all endpoints in infantile Pompe disease trial

Jul 7Clinical readoutavalglucosidase alfa-ngpt Sanofi

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.